CoVLP
id:
covlp-196-4753204
title:
CoVLP
text:
CoVLP was a COVID-19 vaccine developed by Medicago in Canada and GlaxoSmithKline (GSK). The product and Medicago, Inc. were owned by Mitsubishi who terminated the company and program in February 2023 due to high international market competition for COVID-19 vaccines. It is a coronavirus virus-like particle vaccine grown in the Australian weed, Nicotiana benthamiana. The Medicago method to manufacture CoVLP was a "molecular farming" technology regarded as rapid, low-cost, and safe. It was propose
brand slug:
wiki
category slug:
encyclopedia
description:
COVID-19 vaccine candidate produced in a plant
original url:
https://en.wikipedia.org/wiki/CoVLP
date created:
date modified:
2023-11-08T10:03:41Z
main entity:
{"identifier":"Q97154243","url":"https://www.wikidata.org/entity/Q97154243"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
15